CNS Pharmaceuticals, Inc. (CNSP)
Nasdaq: CNSP · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2018
Who runs CNS Pharmaceuticals, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Levin Rami
CEO and President. First filing Jan 2026, latest Aug 18, 2026, 0 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
13 people on the record since 2019
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Levin Rami | CEO and President | Jan 2026 | Aug 18, 2026 | none |
| O'Loughlin Steve | Chief Financial Officer | Mar 2026 | Mar 4, 2026 | none |
| Faulkner Eric | Chief Technology Officer | Mar 2026 | Mar 4, 2026 | none |
| Climaco John M | Chief Executive Officer | Nov 2019 | Nov 19, 2025 | none |
| Downs Christopher | Chief Financial Officer | Nov 2019 | Nov 19, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Fisher Michal | director | May 2026 | Aug 18, 2026 | none |
| Charles Faith L. | director | Jan 2023 | May 20, 2026 | none |
| Cockroft Bettina M. | director | May 2023 | Nov 19, 2025 | none |
| Gumulka Jerzy | director | Nov 2019 | Nov 19, 2025 | none |
| Keyes Jeffry R. | director | Nov 2019 | Nov 19, 2025 | none |
| Mahery Amy | director | Feb 2024 | Nov 19, 2025 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.